Gilead Sciences Canada, Inc. announced that Paul Petrelli joined the organization as Vice President and General Manager. In his new role, Petrelli will lead the commercial organization for Gilead Canada, focusing on expanding access to Gilead's therapies, driving sustainable growth and building an inclusive and collaborative employee culture.
Petrelli is a respected leader in the Canadian biotech industry with a proven track record of commercial excellence, a focus on supporting high-performing culture and people development, and experience leading teams in diverse markets including in Canada, Europe, and the US. He brings 20+ years of expertise across nearly every aspect of the pharmaceutical sector, including product lifecycle management and a deep understanding of sales, marketing, market access, medical, government relations, regulatory and more.
Before joining Gilead Canada, Paul most recently led Jazz Pharmaceuticals, where he built their Canadian organization over the past 7 years. His prior commercial experience also includes increasingly senior commercial roles at GSK, AstraZeneca and Biogen.
"It's a privilege to join an organization that's been at the forefront of groundbreaking scientific and societal progress, with a strong legacy in transforming lives through innovations in viral hepatitis, and HIV," said Petrelli. "Partnerships continue to be a key focus for me and for Gilead Canada. We share the same priorities of our community, medical, academic and government partners, and I'm excited to deepen our relationships to make a meaningful impact for Canadians across all our therapeutic areas."
Petrelli is based at Gilead Canada's head office in Mississauga, Ontario.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!